Process Development

We follow our clients along the drug development value chain, taking the results from the lab to the pilot plant, developing new robust, reliable and cost-effective processes. We have an expert staff dedicated to the design and development of an economical, reproducible and scalable synthetic route that ultimately will obtain a product that complies with the market’s strict purity requirements.

Our joint venture with Applus+, GalChimiApplus, allow us to deliver pilot plant batches for preclinical work and also GMP batches of product for Phase I studies. Check the GalChimiApplus website for more info about our expertise and capabilities.